Table 2.
Tumor | Area (cm)2 | Volume (cm)3 | Invasion Depth (cm) | Lymph Nodes (Number) with ENE | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
stage I ENE(-) | 1.3 | ± | 0.9 | 0.7 | ± | 0.9 | 0.45 | ± | 0.27 | -- | ||
stage II ENE(-) | 5.0 | ± | 2.9 | 6.2 | ± | 5.7 | 1.06 | ± | 0.46 | -- | ||
stage III ENE(-) | 8.7 | ± | 5.4 | 11.9 | ± | 10.2 | 1.06 | ± | 0.54 | -- | ||
stage IV ENE(-) | 15.7 | ± | 10.1 | 47.3 | ± | 48.1 | 2.23 | ± | 1.45 | -- | ||
stage IV ENE(+) | 17.9 | ± | 16.4 | 61.3 | ± | 83.7 | 2.38 | ± | 1.77 | 2.9 | ± | 2.5 |
Abbreviations: ENE, extranodal extension; ENE(-), ENE negative; ENE(+), ENE positive.